1. FDA. CLIA—Tests Waived by FDA from January 2000 to Present 2017 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfClia/testswaived.cfm.
2. Weiss A. Concurrent engineering for lateral-flow diagnostics. IVD Technology [Internet]. 1999 January 29, 2018.
3. Clinically relevant analytical techniques, organizational concepts for application and future perspectives of point-of-care testing;Luppa;Biotechnol Adv,2016
4. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening;George;Addiction,1995
5. Potential risk of patient misclassification using a point-of-care testing kit for urine drugs of abuse;Matthews;Br J Biomed Sci,2010